Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 May;59(5):503.

Vitamins for age-related macular degeneration demonstrate minimal differences

Michael R Kolber  1 , Mathew Tennant, Tony Nickonchuk
Affiliations
Randomized Controlled Trial

Vitamins for age-related macular degeneration demonstrate minimal differences

Michael R Kolber et al. Can Fam Physician. 2013 May.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Age-Related Eye Disease Study Research Group A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol. 2001;119(10):1417–36. - PMC - PubMed
    1. Evans JR. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev. 2006;(2):CD000254. - PubMed
    1. The Eye Diseases Prevalence Research Group Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122(4):477–85. - PubMed
    1. Jager RD, Mieler WF, Miller JW. Age-related macular degeneration. N Engl J Med. 2008;358(24):2606–17. - PubMed
    1. Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL, 3rd, Age-Related Eye Disease Study Research Group Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study. Ophthalmology. 2005;112(4):533–9. - PMC - PubMed

Publication types